Provided by Tiger Trade Technology Pte. Ltd.

Merck

143.93
-0.7800-0.54%
Post-market: 143.92-0.0100-0.01%19:04 EDT
Volume:8.68M
Turnover:1.25B
Market Cap:355.10B
PE:113.08
High:145.90
Open:145.52
Low:143.68
Close:144.71
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.14
T/O Rate:0.35%
Dividend:3.36
Dividend Rate:2.33%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.47
PE(LYR):19.77

Loading ...

Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’

Benzinga
·
Jun 26

UBS Remains a Buy on Merck KGaA (0O14)

TIPRANKS
·
Jun 26

Barclays Sticks to Their Buy Rating for Merck & Company (MRK)

TIPRANKS
·
Jun 26

Barclays Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Jun 26

PRESS Digest-financial Times - June 26

Reuters
·
Jun 26

Movement Alert|Merck Rises 3.08% in Regular Trading, Keytruda Plus Trodelvy Wins FDA Approval for Triple-Negative Breast Cancer

Market Focus
·
Jun 26

The Dow Hits Record High, Caterpillar Surges Over 5%

Tiger Newspress
·
Jun 25

Bio-Techne Surges as Merck Agrees to Acquire Company at $73 Per Share in Cash

Market Focus
·
Jun 25

Merck Gains FDA Approval for Keytruda Plus Trodelvy in PD-L1 Positive Breast Cancer

MT Newswires Live
·
Jun 25

Merck says FDA approves Keytruda and Keytruda Qlex in combo with Trodelvy

TIPRANKS
·
Jun 25

FDA Approves Keytruda® (pembrolizumab) and Keytruda Qlex™ (pembrolizumab and Berahyaluronidase Alfa-pmph), Each with Trodelvy® (sacituzumab Govitecan-hziy) as First-line Treatment of Pd-l1+ (CPS ≥10) Advanced Triple-negative Breast Cancer (tnbc)

THOMSON REUTERS
·
Jun 25

Alerts Incorrectly Tagged to Merck & Co Withdrawn

Reuters
·
Jun 25

Major Deals Involving US Drugmakers and Biotechs over the Past Decade

Reuters
·
Jun 25

Germany's Merck Boosts Life Sciences Business with $11 Billion Bet on Bio-techne

Reuters
·
Jun 25

Merck Reviews Regional Distribution Hub Plan In Abu Dhabi

MT Newswires Live
·
Jun 25

Department of Health Abu Dhabi: Partnership with Msd to Advance Operational Excellence and Expand Access Across Region

THOMSON REUTERS
·
Jun 25

Merck Initiated at Outperform by CICC

Dow Jones
·
Jun 25

Unicef, Gavi Call to Speed Bundibugyo Ebola Vaccine Access

Reuters
·
Jun 25

Merck says EC approves Keytruda plus Padcev combination

TIPRANKS
·
Jun 24

EU Approves Merck Keytruda Plus Padcev for Cisplatin-ineligible Resectable Muscle-invasive Bladder Cancer

Reuters
·
Jun 24